Sigma 2 receptor ligands and therapeutic uses therefor

Details Sigma 2 receptor ligands and therapeutic uses therefor Sigma 2 receptor ligands and therapeutic uses therefor

2007-07-11

2009-11-03

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S112000, C546S183000

Reexamination Certificate

active

07612085

ABSTRACT:
A series of N-substituted 9-azabicyclo[3.3.1]nonan-3α-yl phenylcarbamate analogs are disclosed, as well as methods of their preparation. Their affinities for sigma (σ1 and σ2) receptors are described. Two new compounds, N-(9-(4-aminobutyl)-9-azabicyclo[3.3.1]nonan-3α-yl)-N′-(2-methoxy-5-methylphenyl)carbamate and N-(9-(6-aminohexyl)-9-azabicyclo[3.3.1]nonan-3α-yl)-N′-(2-methoxy-5-methylphenyl)carbamate, are shown to have a high affinity and selectivity for σ2 versus σ1 receptors. Among the disclosed compounds are biotinylated and fluorescent analogs. These compounds can serve as probes to the σ2 receptor. In addition, some disclosed compounds can induce apoptotic cell death by both caspase-dependent and caspase-independent mechanisms, and are effective for treatment of tumors. The compounds can be used as chemotherapeutics or chemosensitizers in the treatment of a wide variety of solid tumors.

REFERENCES:
Efange et al., Journal of Medicinal Chemistry (1997), 40(24), 3905-3914.
Vangveravong et al., Bioorganic & Medicinal Chemistry (2006), 14(20), 6988-6997.
Aydar et al., Cancer research, (Aug. 1, 2004) vol. 64, No. 15, pp. 5029-5035. Ref: 100.
Barbieri et al, Novel sigma binding site ligands as inhibitors of cell proliferation in breast cancer. Oncology Research, 2003, 13:455-461.
Bonhaus et al, [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus. Pharmacol. Exp. Ther. 1993, 267:961-970.
Bowen et al, CB-64D and CB-184: ligands with high sigma 2 receptor affinity and subtype selectivity. Eur. J. Pharmacol. 1995, 278:257-260.
Brent et al, The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+] in colon and mammary adenocarcinoma cells. Biochemical & Biophysical Research Communications, 1996, 219:219-226.
Choi et al, Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent. Nuclear Medicine & Biology, 2001, 28:657-666.
Crawford and Bowen, Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res. 2002, 62:313-322.
Hellewell et al, Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol., Mol. Pharmacol. Sec. 1994, 268:9-18.
Huang et al, Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands. J Med Chem, 2001, 44:4404-4415.
Huang et al, Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands. Journal of Medicinal Chemistry, 1998, 41:2361-2370.
John et al, Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[125I]N-(N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[125I]BP: A Potential Sigma Receptor Marker for Human Prostate Tumors. Nuclear Medicine & Biology, 1998, 25: 189-194.
Kawamura et al, Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies. Nuclear Medicine & Biology, 2003, 30:273-284.
Mach et al, Preparation of a technetium-99m SPECT agent for imaging the sigma-2 receptor status of solid tumors. J Labelled Cpd Radiopharm, 2001, 44: 899-908.
Mach et al, Conformationally-flexible benzamide analogues as dopamine D3 and sigma2 receptor ligands. Bioorganic & Medicinal Chemistry Letters, 2004, 14:195-202.
Mach et al, [18F]N-4'-Fluorobenzyl-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [18F]FDG and [125I]IUDR. Nuclear Medicine & Biology, 2001, 28:451-458.
Mach et al, Sigma2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 1997, 57:156-161.
Mach et al, Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma-2 receptor ligands. Med. Chem. Res. 2003, 11:380-398.
Mach et al, Synthesis and sigma receptor binding affinities of 8-azabicyclo[3.2.1]octan-3alpha-yl and 9-azabicyclo [3.3.1]nonan-3alpha-yl phenyl carbamates. Med. Chem. Res. 2001, 10:339-355.
Nguyen et al, Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Eur. J. Pharmacol. 1996, 311:233-240.
Ostenfeld et al, Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res. 2005, 65:8975-8983.
Tu et al, Carbon-11 labeled sigma2 receptor ligands for imaging breast caner. Nuclear Medicine and Biology, 2005, 32:423-430.
Vangveravong et al, Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands. Bioorg. Med. Chem. 2006, 14: 6988-6997.
Xu et al, [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe. Eur. J. Pharmacol. 2005, 525:8-17.

Affiliated with

Also associated with

Rating

Sigma 2 receptor ligands and therapeutic uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sigma 2 receptor ligands and therapeutic uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sigma 2 receptor ligands and therapeutic uses therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4070516